2025 Annual Meeting | C53 - Debunking Myths in MS

Date Sunday 04/06/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Annette Wundes, MD, F�鶹��ýӳ��

Topic(s) Multiple Sclerosis

Learning Objectives Participants should gain insights into the diagnostic challenges and management strategies for MS, specifically why misdiagnosis of MS remains a problem in clinical practice and ways to increase diagnostic accuracy, the unique aspects of late-onset MS when managing older patients with MS and considerations for family planning, pregnancy, and breastfeeding in MS.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM PDT	Speaker	Introduction Annette Wundes, MD, F�鶹��ýӳ��
07:05 AM - 07:33 AM PDT	Speaker	Avoiding Misdiagnosis of MS: Strategies to Improve Diagnostic Accuracy Andrew Solomon, MD, F�鶹��ýӳ��
07:33 AM - 07:43 AM PDT	Q&A	Questions and Answers Andrew Solomon, MD, F�鶹��ýӳ��
07:44 AM - 08:12 AM PDT	Speaker	Late-onset MS: Diagnostic and Management Considerations Le Hua, MD, F�鶹��ýӳ��
08:12 AM - 08:22 AM PDT	Q&A	Questions and Answers Le Hua, MD, F�鶹��ýӳ��
08:23 AM - 08:50 AM PDT	Speaker	Navigating Family Planning, Pregnancy, and Breastfeeding in MS Annette Wundes, MD, F�鶹��ýӳ��
08:51 AM - 09:00 AM PDT	Q&A	Questions and Answers Annette Wundes, MD, F�鶹��ýӳ��

Faculty Disclosures
Annette Wundes, MD, F�鶹��ýӳ��	The institution of Dr. Wundes has received research support from Benaroya Research Institute .
Andrew Solomon, MD, F�鶹��ýӳ��	Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche . Dr. Solomon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kiniksa Pharmaceuticals . Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Solomon has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Solomon has received research support from Bristol Meyers Squibb.
Le Hua, MD, F�鶹��ýӳ��	Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Hua has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Bioscience. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hua has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TG Therapuetics. The institution of Dr. Hua has received research support from Genentech.